Invited review: Cardiovascular protective effects of 17β-estradiol metabolites

Journal of Applied Physiology

Volumn 91, Issue 4, 2001, Pages 1868-1883

  Dubey, Raghvendra K ^a,b   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cardiac fibroblasts; Catecholestradiol; Endothelium; Estrone; Hydroxyestradiol; Menopause; Methoxyestradiol; Mitogenesis; Vascular smooth muscle

Indexed keywords

CATECHOL ESTROGEN; ESTRADIOL; ESTRADIOL 3 METHYL ETHER; ESTRIOL; ESTRONE;

CARDIOVASCULAR SYSTEM; ESTROGEN THERAPY; FIBROBLAST; HEART PROTECTION; HORMONE ACTION; HORMONE METABOLISM; HUMAN; METABOLITE; MITOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; VASCULAR SMOOTH MUSCLE; ANIMAL; CARDIOVASCULAR DISEASE; FEMALE; GENETICS; GENOME; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ANIMALS; CARDIOVASCULAR DISEASES; ESTRADIOL; FEMALE; GENOME; HUMANS; MALE; SEX CHARACTERISTICS;

EID: 0034807672     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2001.91.4.1868     Document Type: Review

References (101)

1. Catechol estrogens as inhibitors of leukotriene synthesis
2. Estrogen metabolism and excretion in Oriental and Caucasian women
3. 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin
4. Estrogen-induced vasoprotection is estrogen receptor dependent: Evidence from balloon-injured rat carotid model
5. Metabolic clearance rates of catechol estrogens in rats
6. Formation, metabolism, and physiologic importance of catecholestrogens
7. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: Possible role of decreased endothelium-derived superoxide anion production
8. Antimitogenic effects of estradiol on vascular smooth muscle cell (SMC) growth are mediated via estrogen receptor (ER)-independent mechanisms and involve estradiol metabolism
9. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture
10. 17β-estradiol protects neurons from oxidative stress-induced cell death in vitro
11. 125I-labelled ligand
12. Insulin like growth factor-1 and platelet derived growth factor BB induce directed migration of human arterial smooth muscle cells via signalling pathways that are distinct from those of proliferation
13. Androgens inhibit the formation of catechol estrogens by estrogen-2-hydroxylase present in rat liver preparations
14. Neonatal gonadal hormones and blood pressure in the spontaneously hypertensive rat
15. Cardiovascular changes in pregnancy
16. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats
17. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site
18. Effects of a training program on resting plasma 2-hydroxy catecholestrogen levels in eumenorrheic women
19. Vasodilator-derived nitric oxide inhibits fetal calf serum and angiotensin II-induced growth of renal arteriolar smooth muscle cells
20. Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells
21. 17β-estradiol, its metabolites and progesterone inhibit cardiac fibroblast growth
22. Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway
23. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and MAP kinase activity
24. Methoxyestradiols mediate the antimitogenic effects of estradiol on human glomerular mesangial cells (GMCs) via estrogen receptor (ER)-independent mechanism
25. Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast (CF) growth
26. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms
27. Estrogen-induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanisms
28. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism
29. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin 1 receptors
30. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells
31. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth
32. Inhibitory effects of androgens on estradiol metabolism may contribute to the decreased protective effects of estradiol on neointima formation in male rats
33. Metabolism of exogenous 4- and 2-hydroxyestradiol in human male
34. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogensin and suppresses tumor growth
35. Risk of gyneacomastia associated with cimetidin, omeprazole, and other antinuclear drug
36. Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
37. The effect of estrogen replacement therapy with or without progesterone on the fibrinolytic system and coagulation inhibitors in postmenopausal status
38. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase
39. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
40. Expression of oestrogen receptor α and β in rat heart: Role of local oestrogen synthesis
41. Localized expression of aromatase in human vascular tissues
42. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
43. Estrogen inhibits the vascular injury response in estrogen receptor a deficient mice
44. 2-Hydroxyestradiol attenuates the development of obesity, metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats
45. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
46. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins of human coronary artery smooth muscle cell migration
47. Radioimmunoassay and metabolic clearance rate of catecholestrogens, 2-hydroxyestrone and 2-hydroxyestradiol in man
48. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
49. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
50. The isolation and characterization of estradiol-fatty acid esters in human ovarian follicular fluid. Identification of an endogenous long-lived and potent family of estrogens
51. Gonadectomy and hormonal replacement changes systolic blood pressure and ventricular myosin isoenzyme pattern of spontaneously hypertensive rats
52. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery
53. Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro
54. 4-Hydroxylation of estrogens as marker of human mammary tumors
55. Increased expression of estrogen receptor B mRNA in male blood vessels after vascular injury
56. Behavioral stress responses in premenopausal and post-menopausal women and the effects of estrogen
57. The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothelial cells
58. An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats
59. Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells
60. Upregulation of estrogen receptor-α expression in rabbit cardiac allograft
61. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β
62. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors
63. Concentration dependence of prooxidant and antioxidant properties of catechol estrogens
64. P450 enzyme of estrogen metabolism
65. Genotype distribution of estrogen receptor polymorphism in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels
66. Estradiol fatty acid esters. The isolation and identification of the lipoidal derivative of estradiol synthesized in the bovine uterus
67. The protective effects of estrogen on the cardiovascular system
68. Human leukemia inhibitory factor upregulates LDL receptors on liver cells and decreases serum cholesterol in the cholesterol-fed rabbits
69. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis
70. Sex differences in renal hemodynamics in rats
71. Atherosclerosis Risk in Communities Study Investigators: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
72. Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta
73. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment
74. Regulation of cytochrome P450 1A1 gene expression in vascular smooth muscle cells through arylhadrocarbon receptor-mediated signal transduction requires a protein synthesis inhibitor
75. Inhibition of tyrosine hydroxylase in rabbit mesenteric artery and vas deferens by catechol oestrogens
76. Cytochrome P450 enzymes in the heart
77. Inhibitory action of acute estradiol treatment on the activity and quantity of tyrosine hydroxylase in the median eminence of ovariectomized rats
78. Induction and inhibition of uterine vasodilation by catechol estrogen in oophorectomized, non-pregnant eves
79. The pathogenesis of atherosclerosis: A perspective for the 1990s
80. Cellular and biochemical mechanisms by which environmental estrogens may influence the reproduction function
81. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women
82. Effect of estradiol metabolites on the susceptibility of low density lipoproteins to oxidation
83. Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures
84. Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure SHHF/Mac-facp rats
85. The impact of gender on the progression of chronic renal disease
86. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man
87. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene
88. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation
89. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalysed oxidation of low or high density lipoproteins: Antioxidative effects of steroids on lipoproteins
90. Induction of CYP1A1 and formation of toxic metabolites of benzo(a)pyrene by rat aorta: A possible role in atherosclerosis
91. Gene expression in distinct regions of the heart
92. Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat
93. 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and β-galactosidase expression in vascular endothelial cells
94. Modulation of growth factor action. Implications for the treatment of cardiovascular diseases
95. Molecular effects of genistein on estrogen receptor mediated pathways
96. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth
97. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and Fas expression
98. Catecholamines abrogate the antimitogenic effects of 2-hydroxy metabolite of estradiol on vascular smooth muscle cells by inhibiting catechol-O-methyltransferase (COMT) activity and 2-methoxyestradiol formation
99. Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells
100. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis
101. Functional role of estrogen metabolism in target cells: Review and perspectives